My comment was directed at ROEROC as he/she obviously doesn’t like shorters, but I was pointing out that they serve a purpose in the investment world. The checkmate report isn’t in the same league as the Glaucus Research take down of BLA. Well researched shorters offer a counter balance to irrational exuberance and rampant pumpers on social media and any investor worth their salt should welcome counter views as it allows them to keep their own bias in check.
CCP Price at posting:
$17.46 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)